NICE recommends innovative treatment for type 1 diabetes
It’s estimated that around 90,000 people could be eligible for treatment with dapagliflozin
Latest news headlines
Dacomitinib has been recommended as a first-line treatment option for people with a type of non-small-cell lung cancer (NSCLC), in new NICE guidance.
05 July 2019
More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza after NICE today (3 July) published amended draft guidance following a proposal for extending the terms of the managed access agreement (MAA) between NHS England and Biogen for funding it.
03 July 2019
NICE has urged local authorities and the public to be aware of the air quality in their homes and to reduce their exposure to indoor pollutants.
28 June 2019
People living with dementia should be offered activities such as exercise, aromatherapy, art, gardening, baking, reminiscence therapy, music therapy, mindfulness and animal assisted therapy to help promote their wellbeing.
28 June 2019
Consultation on proposal open until Friday 13 September
25 June 2019
People with recurrent non-infectious uveitis affecting the back of the eye could benefit from a new treatment option, the fluocinolone acetonide implant, as a result of new NICE guidance published today.
20 June 2019